Edwards Lifesciences
在场
是其中之一......
Edwards Lifesciences 是一家在股票代码 EW (US) 下上市的公司。
Edwards Lifesciences 在 2 个国家有直接业务。
他们在：
涉及Edwards Lifesciences的并购和融资。
- Edwards Lifesciences has announced the acquisition of JenaValve Technology (公布2024七月26号).
高管
查看带有其 40 名主要高管的组织结构图
Edwards Lifesciences 搜索最多的简介
- Bernard Zovighian, President and Chief Executive Officer
- Leslie Heisz, Director
- Kieran Gallahue, Director
高管在Edwards Lifesciences变化
- Michael Mussallem, Chairman of the Board, 将于 20245月6 退休 (新闻发布的2024三月29号).
- Nicholas Valeriani 曾任 Director, 将于 20245月6 升职为 Chairman of the Board (新闻发布的2024三月29号).
创建提醒
跟踪 Edwards Lifesciences 的高管变动
生物技术
Edwards Lifesciences 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
- TuHura Biosciences and Kintara Therapeutics have merged (公布2024十月20号)..
生物技术 行业的其他推荐联系人
消息
Edwards Lifesciences 的最新新闻稿
- Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024
- Edwards Lifesciences Completes Sale of Critical Care
- Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
- Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
- Edwards Lifesciences to Sell Critical Care to BD
- Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
- Edwards Lifesciences Reports First Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
- Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
- Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
- View more press releases Close
通过电子邮件
